Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
Amneal Pharmaceuticals, Inc. Class A Common Stock
XNAS:AMRX
12.18
2.01%

Ask
$18.36 - 100.00
Bid
$11.90 - 5.00
Low
$11.9
High
$12.22
Open
$12.01
Prev Close
$11.94
52W High
12.68
52W Low
6.69
Volume
2363105
Avg Vol (3m)
1918665.3
Float
156636394.56
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 05/07/2018
Primary Exchange: XNAS

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Phone: (908) 947-3120
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
8,100
P/E (TTM)
840.845070
P/B (TTM)
-34.974900
Round Lot
100
Composit FIGI
BBG00462PGG0
Share Class FIGI
BBG00462PGH9
Share Class Shares Outstanding
314.08M
Weighted Shares Outstanding
314.36M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own AMRX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.